Xenon Pharmaceuticals (XENE) Preferred Dividend Payments (2013 - 2014)
Xenon Pharmaceuticals' (XENE) quarterly Preferred Dividend Payments came in at $5.6 million in Q3 2014, up 10.61% year-on-year from $5.1 million in Q3 2013, and up 354.96% on a QoQ basis from $1.2 million in Q2 2014.
Xenon Pharmaceuticals (XENE) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 2 years of Preferred Dividend Payments data on file, last reported at $5.6 million in Q3 2014.
- On a quarterly basis, Preferred Dividend Payments rose 10.61% year-over-year to $5.6 million in Q3 2014; TTM through Sep 2014 was $8.2 million, a N/A change from a year earlier, with the FY2013 full-year figure at $8.2 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q3 2014 stood at $5.6 million, up from $1.2 million in the prior quarter.
- Over the last five years, Preferred Dividend Payments for XENE reached as high as $5.6 million in Q3 2014 and fell as low as $1.2 million in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 5.60 Mn |
| Jun 30, 2014 | 1.23 Mn |
| Mar 31, 2014 | 1.37 Mn |
| Sep 30, 2013 | 5.06 Mn |